Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.80
+0.18 (2.36%)
Jul 31, 2026, 4:08 PM HKT

Medlive Technology Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Medlive Technology stock has a consensus rating of "Strong Buy" and an average price target of $12.58. The average 1-year stock price forecast is 61.28% higher than the current stock price, while the lowest is $11.02 (+41.28%) and the highest is $17.17 (+120.13%).

Price Target: $12.58 (+61.28%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$11.02$12.58$11.58$17.17
Change+41.28%+61.28%+48.46%+120.13%

Analyst Ratings

The average analyst rating for Medlive Technology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingDec '25Jan '26Feb '26Mar '26Apr '26Jul '26
Strong Buy434555
Buy000000
Hold111000
Sell000000
Strong Sell000000
Total545555

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
HSBC
No rating
HSBC
Buy
Maintains
$12.00
BuyMaintains$12.00+53.85%Jul 22, 2026
Unknown Analyst
Citic Securities
No rating
Citic Securities
Buy
Maintains
$17.00
BuyMaintains$17.00+117.95%Apr 13, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$11.40
BuyMaintains$11.40+46.15%Apr 2, 2026
Unknown Analyst
Guotai Haitong
No rating
Guotai Haitong
Buy
Maintains
$10.90
BuyMaintains$10.90+39.74%Mar 31, 2026

Financial Forecast

Revenue This Year
747.19M
from 642.16M
Increased by 16.36%
Revenue Next Year
877.23M
from 747.19M
Increased by 17.40%
EPS This Year
0.52
from 0.46
Increased by 11.97%
EPS Next Year
0.59
from 0.52
Increased by 13.94%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
284.44M314.05M412.00M558.46M642.16M747.19M
Revenue Growth
33.21%10.41%31.19%35.55%14.99%16.36%
Gross Profit
200.73M212.74M251.34M327.22M385.44M445.33M
Gross Margin
70.57%67.74%61.00%58.59%60.02%59.60%
Operating Income
61.60M59.82M65.01M117.44M167.36M245.98M
Net Income
40.62M117.32M242.30M315.15M334.34M349.05M
EPS
----0.460.52
EPS Growth
----10.85%11.97%
Forward PE
6.2145.7347.2524.6818.1912.91
Dividend / Share
0.020.070.230.260.260.24
Dividend Growth
-284.71%253.98%11.06%1.17%-6.54%
Free Cash Flow
64.42M43.61M48.96M46.04M62.40M197.00M
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High793.0M
Avg747.2M
Low690.2M

Revenue Growth

Revenue Growth202620272028
High
23.5%
Avg
16.4%
Low
7.5%

EPS Forecast

EPS202620272028
High0.53
Avg0.52
Low0.51

EPS Growth

EPS Growth202620272028
High
14.1%
Avg
12.0%
Low
9.8%